Free Trial

INSPECS Group (SPEC) Competitors

INSPECS Group logo
GBX 45.26 -0.24 (-0.53%)
As of 10:48 AM Eastern

SPEC vs. BVC, AKR, CNSL, ODX, CTEC, AMS, TSTL, CIR, BVXP, and EKF

Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Tristel (TSTL), Circassia Group (CIR), Bioventix (BVXP), and EKF Diagnostics (EKF). These companies are all part of the "medical" sector.

INSPECS Group vs. Its Competitors

INSPECS Group (LON:SPEC) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 2.2%. BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 6.4%. INSPECS Group pays out -24.8% of its earnings in the form of a dividend. BATM Advanced Communications pays out -2,321.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. BATM Advanced Communications is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, INSPECS Group had 1 more articles in the media than BATM Advanced Communications. MarketBeat recorded 1 mentions for INSPECS Group and 0 mentions for BATM Advanced Communications. INSPECS Group's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
INSPECS Group Neutral
BATM Advanced Communications Neutral

BATM Advanced Communications has lower revenue, but higher earnings than INSPECS Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than INSPECS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£195.14M0.24-£4.11M-£4.04-11.20
BATM Advanced Communications£130.32M0.64-£278.26K-£0.04-363.32

67.8% of INSPECS Group shares are owned by institutional investors. Comparatively, 42.4% of BATM Advanced Communications shares are owned by institutional investors. 25.6% of INSPECS Group shares are owned by insiders. Comparatively, 26.2% of BATM Advanced Communications shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

BATM Advanced Communications has a net margin of -0.21% compared to INSPECS Group's net margin of -2.10%. BATM Advanced Communications' return on equity of -0.22% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-2.10% -4.00% 0.45%
BATM Advanced Communications -0.21%-0.22%0.58%

INSPECS Group has a beta of 2.22, meaning that its stock price is 122% more volatile than the S&P 500. Comparatively, BATM Advanced Communications has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500.

Summary

BATM Advanced Communications beats INSPECS Group on 9 of the 14 factors compared between the two stocks.

Get INSPECS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£46.02M£3.12B£5.45B£3.07B
Dividend Yield2.00%1.99%3.99%5.03%
P/E Ratio-11.2017.5030.11170.63
Price / Sales0.24350.73379.55303,754.90
Price / Cash1.63146.5435.9427.96
Price / Book0.452.428.134.52
Net Income-£4.11M£99.80M£3.26B£5.90B
7 Day Performance7.76%0.47%1.15%1.25%
1 Month Performance-9.30%-5.25%2.81%3.74%
1 Year Performance-12.96%115.96%28.41%58.02%

INSPECS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
INSPECS Group
N/AGBX 45.26
-0.5%
N/A-12.0%£46.02M£195.14M-11.201,673Gap Up
BVC
BATM Advanced Communications
N/AGBX 16.90
+2.4%
N/A-24.3%£89.75M£130.32M-392.34980Gap Down
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.32
-11.5%
N/A-2.5%£7.90M£9.77M-362.103,200Gap Up
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
2.7981 of 5 stars
GBX 235.40
+1.9%
GBX 303
+28.7%
+0.4%£5.99B£2.71B39.6410,000
AMS
Advanced Medical Solutions Group
2.8434 of 5 stars
GBX 198.40
-0.6%
GBX 287.50
+44.9%
-13.0%£428.40M£132.18M38.4510Positive News
TSTL
Tristel
N/AGBX 380
-0.4%
GBX 400
+5.3%
-23.0%£181.53M£42.24M27.81208Gap Up
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
BVXP
Bioventix
N/AGBX 2,648
-1.0%
N/A-44.0%£138.66M£13.65M17.1312Positive News
EKF
EKF Diagnostics
N/AGBX 30.24
+3.6%
N/A+9.5%£134.40M£49.91M28.14356News Coverage

Related Companies and Tools


This page (LON:SPEC) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners